Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith M Hessel

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Thorax|January 28, 2014
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in miceJohn D Campbell, Sariah A Kell, Heather M Kozy, et al.
American Journal of Respiratory and Critical Care Medicine|April 12, 2016
Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase InhibitionJatinder K Juss, David House, Augustin Amour, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2018
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled AsthmaSanjeev Khindri, Anthony Cahn, Malcolm Begg, et al.
The Journal of Clinical Investigation|September 4, 2009
CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humansJohn D Campbell, Yan Cho, Martyn L Foster, et al.
Clinical Pharmacology and Therapeutics|November 15, 2017
First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-ToleratedSam Jackson, Albert F Candia, Stephen Delaney, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 2019
An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male SubjectsAndrew W Harrell, Robert Wilson, Yau Lun Man, et al.
American Journal of Respiratory Cell and Molecular Biology|June 28, 2021
Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene SignaturesSabine Wronski, Soren Beinke, Helena Obernolte, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized TrialAnthony Cahn, J Nicole Hamblin, Jon Robertson, et al.
Scientific Reports|December 15, 2019
Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damageBraulio Henrique Freire Lima, Pedro Elias Marques, Lindisley Ferreira Gomides, et al.
Nature Communications|August 11, 2018
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent mannerAnne-Katrien Stark, Anita Chandra, Krishnendu Chakraborty, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Thorax|January 28, 2014
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in miceJohn D Campbell, Sariah A Kell, Heather M Kozy, et al.
American Journal of Respiratory and Critical Care Medicine|April 12, 2016
Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase InhibitionJatinder K Juss, David House, Augustin Amour, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2018
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled AsthmaSanjeev Khindri, Anthony Cahn, Malcolm Begg, et al.
The Journal of Clinical Investigation|September 4, 2009
CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humansJohn D Campbell, Yan Cho, Martyn L Foster, et al.
Clinical Pharmacology and Therapeutics|November 15, 2017
First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-ToleratedSam Jackson, Albert F Candia, Stephen Delaney, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 2019
An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male SubjectsAndrew W Harrell, Robert Wilson, Yau Lun Man, et al.
American Journal of Respiratory Cell and Molecular Biology|June 28, 2021
Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene SignaturesSabine Wronski, Soren Beinke, Helena Obernolte, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized TrialAnthony Cahn, J Nicole Hamblin, Jon Robertson, et al.
Scientific Reports|December 15, 2019
Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damageBraulio Henrique Freire Lima, Pedro Elias Marques, Lindisley Ferreira Gomides, et al.
Nature Communications|August 11, 2018
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent mannerAnne-Katrien Stark, Anita Chandra, Krishnendu Chakraborty, et al.
Pageof 6